Online Trial Tracker - Larvol Sigma

HR20013 / Jiangsu Hengrui Pharma

Welcome, Profile Billing Logout

1 Trials

All TrialsPhase 1

Trial + Data / Events

Status

Region

Interventions

Sponsor

Conditions

Primary compl

Study compl

HR20013 / Jiangsu Hengrui Pharma

NCT05465681: Study of HR20013 for Injection in Patients With Malignant Solid Tumors

Completed

RoW

HR20013 for injection；dexamethason

Fujian Shengdi Pharmaceutical Co., Ltd.

Prevention of Nausea and Vomiting Caused by Highly Emetogenic Chemotherapy

01/23

Download Options



	Diseases Companies Products Productz Mechanisms of Action Sites